Ramsay Health Care gets $14.8 billion bid from KKR-led consortium; shares soar

The non-binding proposal of A$88 cash per share represents a premium of nearly 37% to Ramsay’s Tuesday closing price of A$64.39. The offer sent the hospital operator’s shares up as much as 29.8% to A$83.55 in early trade, their biggest-ever intraday jump.

Ramsay said in a statement it would provide the KKR-led consortium with due diligence on a non-exclusive basis and talks were at a preliminary stage.

The hospital operator said it had reviewed the proposal with its advisers and asked for further information from the consortium in relation to its funding and structure of the deal.

KKR did not immediately respond to a Reuters request for comment.

If successful, the takeover would be the biggest in Australia this year and nearly double deal activity, which at a total value of $17.4 billion, suffered a 41.2% decline in the first quarter from a year earlier, according to Refinitiv data.

The proposal comes as record-low interest rates prompt private equity firms, superannuation and pension funds with ample liquidity to invest in healthcare and infrastructure assets.

The deal would also rank as the biggest private equity-backed buyout of an Australian company. The country has had a flurry of blockbuster takeovers in the past year, including the purchase of Sydney Airport and Block Inc’s takeover of buy-now-pay-later star Afterpay.

The pandemic hit healthcare operators including Ramsay, with the shutdown of non-urgent surgeries, staffing shortages due to isolation regulations, and upward wage pressure weighing on earnings, making the sector relatively affordable for a buyout, compared to a few years ago.

Last year, Australian biopharmaceutical giant CSL Ltd said it would buy Swiss drugmaker Vifor Pharma AG for $11.7 billion.

The deal would represent a substantial return for the Paul Ramsay Foundation, the company’s biggest shareholder with an 18.8% stake.

Started by Paul Ramsay in 1964 by converting a Sydney guest house into one of the country’s first psychiatric hospitals, the Foundation sold nearly 11% of the company in 2019 for A$61.80 per share, far lower than KKR’s indicative price.

The foundation did not immediately respond to a request for comment from Reuters.

Ramsay operates hospitals and clinics across 10 countries in three continents, with a network of more than 530 locations, according to its website.

It has 72 private hospitals and day surgery units in Australia, while it operates clinics and primary care units in about 350 locations across six countries in Europe.

KKR currently owns French healthcare group Elsan.

Earlier this year, Ramsay and Malaysia’s Sime Darby Holdings received a $1.35 billion buyout offer from IHH Healthcare Bhd for their Asia joint venture. Ramsay said it was still pursuing this transaction.

The hospital operator has hired UBS AG’s Australia Branch and Herbert Smith Freehills as financial and legal advisers, respectively, for the KKR-led consortium’s proposal.

($1 = 1.3535 Australian dollars)

(Reporting by Harish Sridharan in Bengaluru; additional reporting by Byron Kaye in Sydney; Editing by Sriraj Kalluvila, Aditya Soni and Krishna Chandra Eluri and Rashmi Aich)

Source link

0 0 votes
Article Rating

Notifier de
0 Commentaires
Commentaires en ligne
Afficher tous les commentaires
Reset Password

Avertissement sur les risques :

Le trading peut vous exposer à des risques de pertes supérieures aux dépôts et ne convient qu’à une clientèle avisée ayant les moyens financiers de supporter un tel risque. Les CFD sont des instruments complexes et présentent un risque élevé de perte rapide en capital en raison de l’effet de levier. Entre 74 et 89% des comptes de clients de détail perdent de l’argent lors de la négociation de CFD. Vous devez vous assurer que vous comprenez comment les CFD fonctionnent et que vous pouvez vous permettre de prendre le risque élevé de perdre votre argent. Ce site n’est en aucun cas une offre de conseil en investissement ni une incitation quelconque à acheter ou vendre des instruments financiers. Trader le Forex et/ou les CFD’s implique un niveau de risque élevé, et peut ne pas être approprié car vous pouvez subir des pertes supérieures à votre dépôt. L’effet de levier peut être en votre défaveur.

Vous devez être conscient et avoir une compréhension complète de tous les risques associés au marché et au trading. Le site peut être amené à produire des commentaires d’ordre général, ce qui ne constitue pas des conseils en investissement et ne doit pas être interprété comme tel.

Veuillez recourir aux conseils d’un conseiller financier extérieur. Le site décline toute responsabilité pour les erreurs, inexactitudes ou omissions et ne garantit pas l’exactitude ou le caractère complet des informations, textes, graphiques, liens ou autres éléments contenus dans cette documentation. Toute information et toute mise à disposition sur le site ont un caractère privé.